In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors. - Wikidata - awgldk - TriplyDB

In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors.

In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors.

http://www.wikidata.org/entity/Q34454464

about

Mesenchymal-to-endothelial transition in Kaposi sarcoma: a histogenetic hypothesis based on a case series and literature review Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine Developing stem cell therapies for juvenile and adult-onset Huntington's disease Immunomodulation by mesenchymal stem cells in veterinary species Mesenchymal Stem Cells Enhance Nerve Regeneration in a Rat Sciatic Nerve Repair and Hindlimb Transplant Model.Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates Puromycin-resistant lentiviral control shRNA vector, pLKO.1 induces unexpected cellular differentiation of P19 embryonic stem cells.Use of Genetically Altered Stem Cells for the Treatment of Huntington's Disease.Repetitive busulfan administration after hematopoietic stem cell gene therapy associated with a dominant HDAC7 clone in a nonhuman primate.Mesenchymal stem cells for the treatment of neurodegenerative disease.Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells.Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease Rat Nasal Respiratory Mucosa-Derived Ectomesenchymal Stem Cells Differentiate into Schwann-Like Cells Promoting the Differentiation of PC12 Cells and Forming Myelin In Vitro.Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury.Specific transduction of HIV-susceptible cells for CCR5 knockdown and resistance to HIV infection: a novel method for targeted gene therapy and intracellular immunization.Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products.Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin.Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.Delivery of nucleic acid therapeutics by genetically engineered hematopoietic stem cells.Concise review: managing genotoxicity in the therapeutic modification of stem cells.Stem cell therapy: from bench to bedside.Engineered BDNF producing cells as a potential treatment for neurologic disease.Effects of lentiviral vector-mediated TRADD expression on the inhibition of hypertrophic scar formation.Complementary treatment of siTERT for improving the antitumor effect of TERT-specific I-131 therapy.Viral Vector Biosafety in Laboratory Animal Research.Analysis of post-transcriptional regulations by a functional, integrated, and quantitative method.The Complex Ethics of First In Human Stem Cell Clinical Trials.Mesenchymal stem cells for trinucleotide repeat disorders Comparison of chloromethyl-dialkylcarbocyanine and green fluorescent protein for labeling human umbilical mesenchymal stem cells.Engineered Hematopoietic Stem Cells as Therapeutics for Hemophilia A."Next-generation" mesenchymal stem or stromal cells for the in vivo delivery of bioactive factors: progressing toward the clinic.Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.Genetically engineered mesenchymal stem cells: The ongoing research for bone tissue engineering.Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses.

P2860

Q21132551-7F02717B-C4A4-468F-B9BB-662BF00DB4A6 Q24646217-82DF09E0-F362-4C2E-BCCD-EBC59017E3C0 Q24646497-09932066-1529-401D-A5B7-910388126983 Q26751506-28F34964-A079-475D-90C7-D7D49BCDE000 Q26799722-D08B1D40-6546-44B9-BED5-8B56AC5CDA83 Q26822818-32CF3BC7-A306-40F4-A9D6-1EF9F481C428 Q27318332-DB923267-AC72-4A4C-A4D8-BB78BA7E9AE9 Q33713075-86457D4A-AD51-4451-A5DE-C04D4C88E00C Q33772540-8991631D-705A-45E5-8E5C-D9C959504CAE Q33788929-D863EDDD-7D47-43D6-95A0-C46BABC54F4F Q34123262-B3274944-5579-4A98-AFFF-3C5DC80D7905 Q34473474-5BED34F1-2F35-43B5-BFE2-811522B548D9 Q34997203-5BF4CCCD-9199-49AE-871F-9857FFEB0F9D Q35675598-8023F2CD-F91B-4EB4-947F-C3ECE7BB2962 Q35962750-F378BB70-E361-4B61-885B-93089D5EC397 Q36440734-4400B842-09D8-48D3-9FC1-E284E0FF6071 Q37184391-7383FB49-B4EB-4C75-B720-791C44668CF9 Q37200221-EFBACAE1-7E71-417A-BA64-A8094540845F Q37200224-D30C2FBD-BF4C-40B2-B40B-9CDEBA998FBF Q37200247-A250BC8F-7595-4006-B6F0-E2F732DD517C Q37273656-7FEC0CAE-0648-4EA5-8A21-0EE1CD368C95 Q37792339-C1E91CBE-E1AD-4E5C-92BD-4A2F0B10876E Q37928593-3F456B2B-1392-4925-B0AC-DB13D47D56DA Q38042584-F0E68A4A-3FF3-4C0F-AFE7-41BEED60FDEE Q38829577-ACB0BB5A-1A75-4672-BC4F-F2E1BB60C762 Q38981579-0985E8A0-5B87-4844-8673-127F361ED990 Q39402250-9D23BB8B-BA18-4BB1-8503-95CC0A921888 Q39405329-E8A52213-E4AC-43BA-90A9-4956433A23FD Q39857515-FCB8E984-2B23-48C3-AA62-5217309A3DD2 Q41872607-939F2608-B5CF-43AA-8520-EC3599E3C374 Q42030016-D160001D-2602-4199-8ACC-4AB24E2EB06F Q42184792-DDBBF278-F665-45EE-86B9-D344645D89D6 Q42975417-7499ACCF-718F-4FA0-A38C-329F3C402F16 Q45294454-17A46AF6-68F9-4F17-89F0-90463F2DF477 Q48132718-34D1183F-127F-417C-ADBC-FB8378F7AF80 Q48828725-0AE999A8-AA6C-4463-A486-DA5F90402022 Q55091426-0F287B07-BF0D-4C75-B32D-BD775EE96120

P2860

In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors.

http://www.wikidata.org/entity/Q34454464

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

In vivo biosafety model to ass ...... oviral and lentiviral vectors.

@ast

In vivo biosafety model to ass ...... oviral and lentiviral vectors.

@en

In vivo biosafety model to ass ...... oviral and lentiviral vectors.

@nl

type

label

In vivo biosafety model to ass ...... oviral and lentiviral vectors.

@ast

In vivo biosafety model to ass ...... oviral and lentiviral vectors.

@en

In vivo biosafety model to ass ...... oviral and lentiviral vectors.

@nl

prefLabel

In vivo biosafety model to ass ...... oviral and lentiviral vectors.

@ast

In vivo biosafety model to ass ...... oviral and lentiviral vectors.

@en

In vivo biosafety model to ass ...... oviral and lentiviral vectors.

@nl

P1433

Q34454464-11203064-2C45-4FE3-9610-C3FB37ECB0EE

P1476

Q34454464-4920E965-0303-413B-B8D3-CE50A49F7B7E

P2093

Q34454464-02FD15D6-98CF-4240-86E5-D6ADDDF102CE

Q34454464-18D9381A-CCBD-4892-9F58-AAA5BF7D92C9

Q34454464-19A40620-F91F-4E11-BE60-5C218F42EA75

Q34454464-305F255A-4739-45A9-8F3F-431371AA6C51

Q34454464-37105925-F3E9-4323-B809-4AE1CB54BBA1

Q34454464-4EF5CFF6-B666-4A64-A4BF-22481A112F5A

Q34454464-664D0761-36AD-42B8-B179-066A5700BB9C

Q34454464-79BA2811-EFE4-44D6-8189-2DD48B411BAE

Q34454464-7B3FE312-3005-49EE-8099-89269C8D2F48

Q34454464-804339CB-33C1-4DC2-A2ED-0B8D02E8FAF3

P2860

Q34454464-0B5D9F97-9EAC-420D-85DF-78B6D658D6DA

Q34454464-0E9241E3-19AB-4979-844D-B28DF8809C1A

Q34454464-199467C5-AA61-4281-A419-7EC5035BA4E5

Q34454464-1AEFC87A-F4FF-4A73-8F4B-6BF45DBEC188

Q34454464-1F590CF6-721D-42DF-99A9-F7C6F34CEAD6

Q34454464-2DC25677-B639-447F-9EA6-D1D2A5F989CF

Q34454464-3708962C-7D8A-4A37-8472-C6D8A46089B1

Q34454464-5E3C9D10-99D9-4F0D-A02A-051C72A1DB4A

Q34454464-6420B35D-86AF-4B66-BB62-08D910A4459D

Q34454464-66543955-CEDF-48FA-9D1B-490312FEE332

P304

Q34454464-FB7FF141-2656-49F0-AE12-850434DCADE4

P31

Q34454464-A03381BF-6DD5-48FE-A67B-568B646A9990

P356

Q34454464-5326E29D-7013-4F73-9822-2296F2AC04AF

P433

Q34454464-7780F637-C63C-416F-89D8-9ABD7EFF0885

P478

Q34454464-D334297A-8BA6-4102-A7B7-EEF64D73F1F2

P50

Q34454464-CE8212C8-5CBE-422A-A200-B3DF126F47B4

P577

Q34454464-F3FC3116-2DB8-41D5-95BA-D984AFC6508C

P5875

Q34454464-9F9CB32E-4AB4-44C4-AD79-69B8D18CDB14

P698

Q34454464-0BE2B9BC-0281-44D7-92CD-CD8CAA811D65

P932

Q34454464-5D4D63D6-8F44-4FDD-9318-F64F79E7494C

P356

P1433

Molecular Therapy

P1476

In vivo biosafety model to ass ...... oviral and lentiviral vectors.

@en

P2093

Dianne C Skelton

http://www.w3.org/2001/XMLSchema#string

Gerhard Bauer

http://www.w3.org/2001/XMLSchema#string

Jan A Nolta

http://www.w3.org/2001/XMLSchema#string

Jesusa Arevalo

http://www.w3.org/2001/XMLSchema#string

Jon Walker

http://www.w3.org/2001/XMLSchema#string

Karen Pepper

http://www.w3.org/2001/XMLSchema#string

Louisa Wirthlin

http://www.w3.org/2001/XMLSchema#string

Mo A Dao

http://www.w3.org/2001/XMLSchema#string

Phillip Herrbrich

http://www.w3.org/2001/XMLSchema#string

Ping Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Adult rat and human bone marrow stromal cells differentiate into neurons

Marrow stromal cells as stem cells for nonhematopoietic tissues

IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice.

A developmental hypothesis to explain the multicentricity of breast cancer.

Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice.

Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation.

Gene therapy: X-SCID transgene leukaemogenicity.

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors

The use of congenitally immunodeficient mice to study human tumor metastases and immunotherapy.

Immune-deficient mouse models for analysis of human stem cells.

P304

1308-1315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2008.93

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5392127

http://www.w3.org/2001/XMLSchema#string

P698

18461052

http://www.w3.org/2001/XMLSchema#string

P932

3013368

http://www.w3.org/2001/XMLSchema#string